Search research articles
Contact Us
Filters
Showing results (201-210 of 267) with videos related to
Page
of 27
Sort By:
World Journal of Urology
|
March 20, 2025
Comparison of extended and standard lymph node dissection in radical cystectomy for urothelial bladder cancer: a systematic review and meta-analysis
Aleksander Ślusarczyk, Pietro Scilipoti, Gautier Marcq, et al.
European Urology Oncology
|
April 12, 2025
Impact of Histological Subtypes/Divergent Differentiation on Clinicopathological and Oncological Outcomes for Patients with Upper Tract Urothelial Carcinoma Treated with Radical Nephroureterectomy: A Comprehensive Updated Systematic Review and Meta-analysis
Wojciech Krajewski, Łukasz Nowak, Jan Łaszkiewicz, et al.
Cancer Immunology, Immunotherapy : CII
|
June 21, 2022
First-line single-agent pembrolizumab for PD-L1-positive (tumor proportion score ≥ 50%) advanced non-small cell lung cancer in the real world: impact in brain metastasis: a national French multicentric cohort (ESCKEYP GFPC study)
Renaud Descourt, Laurent Greillier, Maurice Perol, et al.
Gut Microbes
|
June 28, 2014
Maternally acquired genotoxic Escherichia coli alters offspring's intestinal homeostasis
Delphine Payros, Thomas Secher, Michèle Boury, et al.
Clinical & Translational Immunology
|
August 22, 2020
Novel combination immunotherapy for pancreatic cancer: potent anti-tumor effects with CD40 agonist and interleukin-15 treatment
Jonas Rm Van Audenaerde, Elly Marcq, Bianca von Scheidt, et al.
European Urology Oncology
|
February 7, 2024
Benefit of Neoadjuvant Cisplatin-based Chemotherapy for Invasive Bladder Cancer Patients Treated with Radiation-based Therapy in a Real-world Setting: An Inverse Probability Treatment Weighted Analysis
Ronald Kool, Alice Dragomir, Girish S Kulkarni, et al.
Molecular Cancer Therapeutics
|
July 16, 2025
TUB-040, a homogenous and hydrophilic NaPi2b-targeting ADC with stably linked exatecan, exhibits long-lasting anti-tumor activity and a well-tolerated safety profile
Annette M Vogl, Saskia Schmitt, Isabelle Mai, et al.
Clinical Lung Cancer
|
October 26, 2019
Phase II Study Evaluating the Mechanisms of Resistance on Tumor Tissue and Liquid Biopsy in Patients With EGFR-mutated Non-pretreated Advanced Lung Cancer Receiving Osimertinib Until and Beyond Radiologic Progression: The MELROSE Trial
Jaafar Bennouna, Nicolas Girard, Clarisse Audigier-Valette, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 3, 2024
Benefit of Whole-Pelvis Radiation for Patients With Muscle-Invasive Bladder Cancer: An Inverse Probability Treatment Weighted Analysis
Gautier Marcq, Ronald Kool, Alice Dragomir, et al.
Oncoimmunology
|
February 6, 2018
Poly(I:C) primes primary human glioblastoma cells for an immune response invigorated by PD-L1 blockade
Jorrit De Waele, Elly Marcq, Jonas Rm Van Audenaerde, et al.
Page
of 27
Search research articles
Search
Showing results (201-210 of 267) with videos related to
Sort By:
Page
of 27
World Journal of Urology
|
March 20, 2025
Comparison of extended and standard lymph node dissection in radical cystectomy for urothelial bladder cancer: a systematic review and meta-analysis
Aleksander Ślusarczyk, Pietro Scilipoti, Gautier Marcq, et al.
European Urology Oncology
|
April 12, 2025
Impact of Histological Subtypes/Divergent Differentiation on Clinicopathological and Oncological Outcomes for Patients with Upper Tract Urothelial Carcinoma Treated with Radical Nephroureterectomy: A Comprehensive Updated Systematic Review and Meta-analysis
Wojciech Krajewski, Łukasz Nowak, Jan Łaszkiewicz, et al.
Cancer Immunology, Immunotherapy : CII
|
June 21, 2022
First-line single-agent pembrolizumab for PD-L1-positive (tumor proportion score ≥ 50%) advanced non-small cell lung cancer in the real world: impact in brain metastasis: a national French multicentric cohort (ESCKEYP GFPC study)
Renaud Descourt, Laurent Greillier, Maurice Perol, et al.
Gut Microbes
|
June 28, 2014
Maternally acquired genotoxic Escherichia coli alters offspring's intestinal homeostasis
Delphine Payros, Thomas Secher, Michèle Boury, et al.
Clinical & Translational Immunology
|
August 22, 2020
Novel combination immunotherapy for pancreatic cancer: potent anti-tumor effects with CD40 agonist and interleukin-15 treatment
Jonas Rm Van Audenaerde, Elly Marcq, Bianca von Scheidt, et al.
European Urology Oncology
|
February 7, 2024
Benefit of Neoadjuvant Cisplatin-based Chemotherapy for Invasive Bladder Cancer Patients Treated with Radiation-based Therapy in a Real-world Setting: An Inverse Probability Treatment Weighted Analysis
Ronald Kool, Alice Dragomir, Girish S Kulkarni, et al.
Molecular Cancer Therapeutics
|
July 16, 2025
TUB-040, a homogenous and hydrophilic NaPi2b-targeting ADC with stably linked exatecan, exhibits long-lasting anti-tumor activity and a well-tolerated safety profile
Annette M Vogl, Saskia Schmitt, Isabelle Mai, et al.
Clinical Lung Cancer
|
October 26, 2019
Phase II Study Evaluating the Mechanisms of Resistance on Tumor Tissue and Liquid Biopsy in Patients With EGFR-mutated Non-pretreated Advanced Lung Cancer Receiving Osimertinib Until and Beyond Radiologic Progression: The MELROSE Trial
Jaafar Bennouna, Nicolas Girard, Clarisse Audigier-Valette, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 3, 2024
Benefit of Whole-Pelvis Radiation for Patients With Muscle-Invasive Bladder Cancer: An Inverse Probability Treatment Weighted Analysis
Gautier Marcq, Ronald Kool, Alice Dragomir, et al.
Oncoimmunology
|
February 6, 2018
Poly(I:C) primes primary human glioblastoma cells for an immune response invigorated by PD-L1 blockade
Jorrit De Waele, Elly Marcq, Jonas Rm Van Audenaerde, et al.
Page
of 27